Emergent BioSolutions (EBS) Tops Q4 EPS by 4c, Beats on Revenues; Offers FY18 Revenues Above Consensus
Go back to Emergent BioSolutions (EBS) Tops Q4 EPS by 4c, Beats on Revenues; Offers FY18 Revenues Above Consensus| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 7.01 -0.01 (0.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.02 | 52 Week High | $44.38 | |||
| Open | $6.98 | 52 Week Low | $24.47 | |||
| Day High | $7.05 | P/E | 350.50 | |||
| Day Low | $6.92 | EPS | $0.02 | |||
| Volume | 219,410 | |||||
